What is Corinth MedTech?
Corinth MedTech operates as a specialized entity within the medical technology sector, focusing on the development and deployment of advanced healthcare solutions. The company occupies a critical niche, bridging the gap between clinical innovation and enterprise-level scalability. By leveraging its robust financial foundation, the organization is able to invest heavily in research and development, ensuring that its product suite remains at the forefront of industry standards. Its market position is characterized by a commitment to high-growth potential, supported by a history of successful capital raises that have enabled the firm to scale its operations and expand its footprint in the global healthcare market.
How much funding has Corinth MedTech raised?
Corinth MedTech has raised a total of $17.2M across 3 funding rounds:
Series D
$12M
Debt
$5M
Debt
$236K
Series D (2019): $12M with participation from ShangBay Capital LLC and Aethan Capital, Inc.
Debt (2020): $5M led by Horizon Technology Finance
Debt (2021): $236K supported by PPP
Key Investors in Corinth MedTech
Horizon Technology Finance
Horizon Technology Finance is a specialty finance company that provides structured debt financing solutions to development-stage companies, focusing on venture lending for businesses backed by venture capital and private equity.
ShangBay Capital LLC
ShangBay Capital LLC is an investment firm that focuses on providing growth capital to innovative companies, often participating in late-stage funding rounds to support scaling efforts.
Aethan Capital, Inc.
Aethan Capital, Inc. is a financial services firm that provides strategic advisory and capital raising services to emerging growth companies across various technology and healthcare sectors.
What's next for Corinth MedTech?
Looking ahead, the strategic deployment of the $236K will likely focus on accelerating product commercialization and enhancing operational efficiencies. With a history of securing both equity and debt financing, Corinth MedTech is well-equipped to navigate the complexities of the current economic environment. The company is expected to prioritize the integration of its core technologies into broader healthcare ecosystems, potentially exploring strategic partnerships or further market penetration. As the firm moves into its next phase of growth, the focus will remain on delivering sustainable value to stakeholders while maintaining the rigorous standards required in the medical technology field. The combination of institutional support and a clear roadmap for innovation positions the company to capitalize on emerging opportunities in the digital health and medical device sectors.
See full Corinth MedTech company page
